Agios Pharmaceuticals, Inc. (AGIO) ownership: Top institutional holder: BlackRock, Inc. ($194.69M). Insider activity: Net Seller (0 buys, 20 sells). 3 recent congressional STOCK Act disclosures. SEC EDGAR first-party data.
| Holder | Shares | Market Value | Reported |
|---|---|---|---|
| BlackRock, Inc. | 5754957.00 | $194.69M | 2026-03-31 |
| FARALLON CAPITAL MANAGEMENT LLC | 5684000.00 | $192.29M | 2026-03-31 |
| VANGUARD GROUP INC | 5594353.00 | $152.28M | 2025-12-31 |
| STATE STREET CORP | 3364879.00 | $113.72M | 2026-03-31 |
| ARMISTICE CAPITAL, LLC | 3200000.00 | $108.26M | 2026-03-31 |
| D. E. Shaw & Co., Inc. | 2681169.00 | $90.70M | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2632316.00 | $89.05M | 2026-03-31 |
| Lynx1 Capital Management LP | 2611568.00 | $88.35M | 2026-03-31 |
| Insider | Transaction | Value | Date |
|---|---|---|---|
| Sell | null | 2026-06-13 | |
| Sell | null | 2026-06-13 | |
| Sell | null | 2026-06-13 | |
| Sell | null | 2026-06-13 | |
| Sell | null | 2026-04-02 | |
| Sell | null | 2026-04-02 | |
| Sell | null | 2026-04-02 | |
| Sell | null | 2026-04-02 |
Back to AGIO overview · AGIO earnings · All congressional trades
Institutional data from SEC Form 13F. Insider data from SEC Form 4. Congressional data from STOCK Act disclosures. Not personalized investment advice.